한국유니온제약
080720KOSDAQ의약품 제조업70.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Korea Union Pharmaceutical focuses on manufacturing and selling specialty pharmaceuticals, exporting finished drugs, and providing CMO (contract manufacturing) services. The company specializes in antibiotics, cardiovascular, and musculoskeletal products, leveraging its GMP facilities and R&D efforts to enhance profitability. It has expanded exports to regions such as the Middle East, Southeast Asia, and South America, and is further expanding its CMO business and product portfolio through a newly completed factory.
Number of Employees
123people
Average Salary
39.2M KRW
Score Calculation Basis
Detailed Financial Score
104.6x industry avg (excellent)
Half of industry avg (excellent)
Avg ▼23.9% (2-year basis)
Avg ▼92.6% (2-year basis)
Avg ROE 88.4% (improving, 3yr)
Detailed News Sentiment
- Negative한국유니온제약, 정리매매 없이 상장폐지 가능성
한국유니온제약의 상장폐지 가능성으로 인해 투자자들의 불안감이 증가하고 주가 하락이 예상됩니다.
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Positive[기재정정]주요사항보고서(유상증자결정)2026-06-09
- Positive[기재정정]주요사항보고서(유상증자결정)2026-06-09
- Neutral[기재정정]주요사항보고서(감자결정)2026-06-09
- Neutral주주총회소집결의 (임시주주총회)2026-06-08
- Neutral주주총회소집공고2026-06-08
